|
Market Closed -
Budapest S.E.
23:19:59 18/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 12,830.00 HUF | +0.39% |
|
+2.39% | +30.06% |
| 09-18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 08-12 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GEDEON RICHTER | Generic Pharmaceuticals | +0.39% | +2.39% | +30.06% | +29.99% | +46.54% | 7.38B |  |  | |
- Stock Market
- Stocks
- RICHTER Stock
- Charts Gedeon Richter
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
